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Benign pharyngoesophageal stricture (PES) is one of 
the most frequent post-treatment morbidities in head 
and neck cancer patients [1]. In fact, the successive inter-
ventions and longer patients’ survival increased the risk 
of related complications. PES is mostly associated with 
radiation therapy in a dose-dependent manner and en-
hanced by combined chemotherapy or surgery [1, 2].
Endoscopic dilation with bougies or balloons is the 
standard treatment in such strictures, with a considerably 
effective technical success rate and an acceptable safety 
profile. Nevertheless, improvement is often transient, re-
quiring recurrent interventions [3]. The goals of therapy 
are the relief of dysphagia, with the avoidance of compli-
cations and the prevention of recurrence. Still, there is no 
universal definition of therapeutic efficacy. Objective as-
sessment of functional outcomes is less consistent due to 
significant heterogeneity in the literature [4]; therefore, 
technical success is most frequently addressed. Kochman 
et al. [3] previously defined recurrent and refractory 
esophageal stricture, which are also commonly used as 
outcome measures.
In this issue of GE – Portuguese Journal of Gastroenter-
ology, Martins et al. [5] report a 3-year experience of treat-
ing pharyngoesophageal strictures at a tertiary oncologic 
center. The overall long-term efficacy of endoscopic dila-
tion program on radiotherapy and anastomotic PES was 
evaluated. Forty-eight patients included in this study un-
derwent a total of 296 dilations. The preferential dilation 
technique consisted in Savary bougies dilation done via 
traditional anterograde access, with a median of 4 dila-
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tions per patient performed with a median interval of 5 
weeks. The authors concluded that their endoscopic dila-
tion program was safe and efficient, especially when pa-
tient perception of improvement was assessed. Remark-
ably, this study presents a median follow-up of 29 months. 
As of now, limited data on long-term follow-up of these 
specific strictures is available. However, as pointed out by 
the authors, the small cohort and the retrospective design 
are important limitations and should be considered when 
evaluating the results.
Martins et al. [5] defined overall efficacy as dysphagia 
improvement based on patient perception and a 6-month 
period of being dilation free and feeding per os. Based on 
their long-term follow-up results, overall efficacy was 
reached in 21 patients (58.8%). A recent meta-analysis [4] 
reported an estimated overall clinical success rate per pa-
tient of 72.9%, though data compared was significantly 
diverse. Moreover, 15 and 29% of patients presented with 
refractory and recurrent PES, respectively, which is in ac-
cordance with the literature [3, 6], and a gastrostomy tube 
independence was achieved in 81% of patients. Notably, 
patient perception of dysphagia improved in 96%. It 
seems that small improvements for the patients, even far 
from the technical endpoints, are worth the laborious 
repetitions. 
Despite the relatively small cohort, Martins et al. [5] 
revealed on univariate analysis that narrow lumens, re-
current strictures, and a higher number of dilations 
(some concept redundancy with recurrence) may pre-
dict worse outcomes. It supports previous data that also 
exposed an increasing number of dilations during the 
first year as a predictive factor for non-responsive PES 
[7] and severely narrowed strictures as a challenging sit-
uation [2, 8]. Although other characteristics with recog-
nized association to difficult treatment in this setting of 
aetiology, as stricture length, complexity, and location 
[8, 9], would add value to this analysis if available in a 
larger population sample. Interestingly, refractory stric-
tures did not present as a worse condition in this popu-
lation and the authors suggested that these patients may 
still benefit from endoscopic therapy. The subjective 
“improvement” of dysphagia included in their definition 
of efficacy may contribute to this. However, it is known 
that the long-term outcome of endoscopic treatment for 
refractory benign esophageal strictures is time-consum-
ing and disappointing with less than one-third of the pa-
tients achieving a resolution of the dysphagia, even when 
other techniques such as steroid injections, incisional 
therapy, stent placement, or self-bouginage are added to 
dilation therapy [5, 9]. Patients and physicians should 
realize that repeated sessions (with inherent risks) and 
visits to the hospital will be needed for a possible effec-
tive treatment.
Martins et al. [5] also reported a low complication rate 
(0.7%), specifically one deep laceration and one fistula. 
The infrequent use of more technically challenging dila-
tion techniques (1%) may have contributed to these re-
sults. A recent metanalysis [4] revealed a higher overall 
complication rate in head and neck cancer patients: 4.4% 
for patients undergoing a standard anterograde dilation 
and 23.3% for patients undergoing combined antero-
grade and retrograde dilation technique. Notably, radia-
tion-induced strictures had the highest perforation rate 
per procedure. Nevertheless, most complications re-
solved with conservative measures. By the way, the com-
monly used rule of 3, also followed by the authors in order 
to minimize the risk of perforation using bougie dilators, 
in a recent study did not prove to reduce the risk of ad-
verse events after esophageal dilation [10].
Although benign PES may be challenging, Martins et 
al. [5] proved that their endoscopic dilation program has 
a reasonable overall efficacy and a good safety profile. It 
can be foreseen that in the future, novel therapies and a 
combination of currently available therapeutic methods 
should be considered, with promising results in reducing 
refractory and recurrent strictures [9, 11, 12]. While wait-
ing for further prospective investigation, narrow diame-
ters, recurrent stenosis, and the need for increased num-
bers of dilations may define a subgroup of patients with 
unfavorable outcome and alert physicians to the use of 
alternative approaches.
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